Dr. Gustavo A. Cardenas, MD

Dr. Cardenas practices at South Palm Cardiovascular Associates in Delray Beach, Florida.

Dr. Cardenas' NPI, 1518009331, was assigned on February 12, 2007. Dr. Cardenas graduated from Universidad del Valle Health Sciences in 1992. Dr. Cardenas holds Florida license ME101884.

Dr. Cardenas' primary practice is South Palm Cardiovascular Associates, at 13550 S Jog Rd, Delray Beach, FL 33446 in Palm Beach County. The practice phone is (561) 515-0080.

Dr. Cardenas' primary practice is South Palm Cardiovascular Associates in Delray Beach, Florida. Dr. Cardenas is also affiliated with Delray Medical Center. The medical group on file is South Palm Cardiovascular Associates. Dmand AI also links Dr. Cardenas to 3 more hospitals, 4 group practices and clinics, 3 medical groups and 1 physician office, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cardenas practices, 9 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Cardenas' primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Cardenas is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Cardenas' licenses on file in 5 states: Florida, Louisiana, Michigan, South Carolina and Ohio.

Dmand AI lists aneurysm, angioplasty, aortic atherosclerois, atrial fibrillation and flutter, cardiac catheterization, cardiomyopathy, cerebrovascular disease and chronic embolism thrombosis among the conditions Dr. Cardenas treats.

CMS data shows 16,201 Medicare services from Dr. Cardenas across 44 procedure codes in 2024, for 1,796 Medicare patients. Medicare paid $1,658,076 for them.

CMS counts 1,796 Medicare patients who saw Dr. Cardenas in 2024. The largest group is 75 to 84, with 765 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 2.08, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Cardenas' median patient age at 76, with 50% women.

In 2024, Dr. Cardenas wrote 5,939 Medicare Part D claims for 973 patients. 80% of them were for generic drugs. CMS names the drug for 5,665 of them, across 57 drugs with 11 or more claims each, at $2,040,696 in total drug cost. In 2023, CMS named 5,158 claims across 57 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Dr. Cardenas for performance year 2024, reported through an alternative payment model (APM). Dr. Cardenas accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 32 procedures of coronary angioplasty and stenting by Dr. Cardenas, more than 68% of the clinicians it reports for that procedure.

Dmand AI links 7 papers to Dr. Cardenas in 2013. The most frequent topics are Cardiovascular Diseases. Dr. Cardenas has published most often in Cleve Clin J Med. Dr. Cardenas' most frequent co-authors are Richard V. Milani, MD, Surya M. Artham, MD, MPH and Carlos Cohen, MD.

Dmand AI links Dr. Cardenas to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Ischemia and Coronary Artery Disease.

CMS Open Payments shows 1,298 general payments to Dr. Cardenas from 75 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 43% of the total. Abbott Laboratories paid the most, $51,839.

Dmand AI lists 1 award for Dr. Cardenas.

Dr. Cardenas graduated from Universidad del Valle Health Sciences in 1992. Dr. Cardenas is a member of ACC and ASH.

Dr. Cardenas is in network with 13 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.